Search

Your search keyword '"Durieu, Isabelle"' showing total 630 results

Search Constraints

Start Over You searched for: Author "Durieu, Isabelle" Remove constraint Author: "Durieu, Isabelle"
630 results on '"Durieu, Isabelle"'

Search Results

1. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

2. Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis

4. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

5. Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children

6. FORAIDMUCO : Pilot implementation of shared decision making in the treatment of diabetes in adult patients with cystic fibrosis: a mixed comparative evaluation of a training program dedicated to cystic fibrosis reference centers (Preprint)

7. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

8. Early-onset autoimmunity associated with SOCS1 haploinsufficiency.

9. Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

10. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

11. Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review

13. Beyond Kaftrio : mechanistic insights to maximize N1303K-CFTR rescue

20. Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.

21. Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rareCFTRvariants: a viewpoint

23. Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis

24. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

26. Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function

28. Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study.

30. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

32. Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

33. Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study: Reply

34. Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series

35. Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age

36. Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study

38. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

39. The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough

43. Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France

45. Tobramycin Therapeutic Drug Monitoring in Adult patients with Cystic Fibrosis: Clinical-Based Empiric Dosing versus Model-Informed Precision Dosing

46. The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508delCFTRvariant

49. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

Catalog

Books, media, physical & digital resources